Drug discovery success stories

<p style="font-weight: 400;">This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “<a href= "https://www.ddw-online.com/global-pharma-start-up-success-stories-17738-202207/">Global pharma start-up success stories</a>”, and “<a href= "https://www.ddw-online.com/excitement-at-rectal-cancer-immunotherapy-breakthrough-18144-202208/">Excitement at rectal cancer immunotherapy breakthrough</a>”.</p> <p>In the first article, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery, from AI to £D deep-learning research to biologics.</p> <p>In the second article, we explore a groundbreaking ‘immuno-ablative’ neo- adjuvant immunotherapy clinical trial that Memorial Sloan Kettering Cancer Center (MSK) has reported has having had a 100% complete response rate in MMRd locally advanced rectal cancer.</p>